PharmaCyte Biotech, Inc.

PMCB

PMCBPharmaCyte Biotech, Inc. US flag

NASDAQ Capital Market

0.34

USD

+0.00

- -

3.67MMarket Cap

Income Statement (USD)

Income Statement API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	2	2	19	13	6	4	7	4	4	4	4	6	7	4	5
+ Selling, General & Admin	1	1	5	3	3	1	3	2	2	1	2	5	6	4	5
+ Research & Development	- -	- -	- -	3	1	1	2	- -	- -	1	1	- -	- -	- -	- -
+ Other Operating Expense	1	1	14	6	2	2	2	2	2	1	2	1	- -	- -	- -
Operating Income (Loss)	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5
- Non-Operating (Income) Loss	- -	- -	8	-3	- -	- -	- -	- -	- -	- -	- -	-2	-7	-35	14
+ Interest Expense, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2	-3	-1	-1
+ Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	3	1	1
+ Other Non-Op (Income) Loss	- -	- -	8	-3	- -	- -	- -	- -	- -	- -	- -	- -	-3	-34	15
Pretax Income	-2	-2	-27	-10	-6	-4	-7	-4	-4	-4	-4	-4	- -	31	-19
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-2	-2	-27	-10	-6	-4	-7	-4	-4	-4	-4	-4	- -	31	-19
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-2	-2	-27	-10	-6	-4	-7	-4	-4	-4	-4	-4	- -	31	-19
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-2	-2	-27	-10	-6	-4	-7	-4	-4	-4	-4	-4	- -	31	-19
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	1	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-2	-2	-27	-10	-6	-4	-7	-4	-4	-4	-4	-4	-2	30	-20
EBIT	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5
EBITDA	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5
EBITDA Margin (%)	-2,891.5	-13,851.65	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITA	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5
Gross Margin (%)	70.88	20.89	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-2,928.55	-13,851.65	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-2,853.62	-13,142.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.03
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	1	1	1	1	1	1	16	19	10	7	8
Basic EPS, GAAP	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	-0.23	4.03	-2.35
Basic EPS from Cont Ops	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	0.03	4.18	-2.32
Diluted Weighted Avg Shares	- -	- -	- -	- -	1	1	1	1	1	1	16	19	10	7	8
Diluted EPS, GAAP	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	-0.23	4.03	-2.35
Diluted EPS from Cont Ops	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	0.03	4.18	-2.32

Balance Sheet (USD)

Balance Sheet API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Total Current Assets	1	2	4	4	2	4	1	1	1	2	85	68	50	22	37
+ Cash, Cash Equivalents & STI	- -	- -	4	3	2	3	1	1	1	2	85	68	50	16	37
+ Cash & Cash Equivalents	- -	- -	4	3	2	3	1	1	1	2	85	68	50	15	19
+ ST Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	1	2	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	- -
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	1	1	5	5	5	5	5	5	5	5	5	5	9	33	9
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	2	2	2	2	2	2	2	2	2	2	- -	22	- -
+ LT Investments	- -	- -	2	2	2	2	2	2	2	2	2	2	- -	22	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	1	1	4	4	4	4	4	4	4	4	4	4	9	10	9
+ Total Intangible Assets	- -	- -	4	4	4	4	4	4	4	4	4	4	2	2	- -
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	4	4	4	4	4	4	4	4	4	4	2	2	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8	9	9
Total Assets	2	3	9	9	7	9	6	6	6	7	91	73	60	55	47
+ Payables & Accruals	2	1	- -	1	- -	1	1	1	1	1	1	1	1	3	1
+ Accounts Payable	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	1	1	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -	2	1
+ ST Debt	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Borrowings	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	2	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	6	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	2	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	6	- -	- -
Total Current Liabilities	4	4	- -	2	1	1	1	1	1	1	1	1	7	3	1
+ LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Borrowings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13	- -	11
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13	- -	11
Total Noncurrent Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13	- -	11
Total Liabilities	4	4	- -	2	1	1	1	1	1	1	1	1	20	3	12
+ Preferred Equity and Hybrid Capital	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12	- -	1
+ Share Capital & APIC	38	40	76	86	91	97	102	105	109	114	202	202	185	181	183
+ Common Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	38	40	76	86	91	97	102	105	109	114	202	202	185	181	183
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14	42	45	45
+ Retained Earnings	-40	-41	-69	-79	-85	-89	-96	-100	-104	-107	-112	-116	-116	-85	-104
+ Other Equity	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-2	-1	9	8	7	8	6	5	5	7	90	73	40	52	35
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	-2	-1	9	8	7	8	6	5	5	7	90	73	40	52	35
Total Liabilities & Equity	2	3	9	9	7	9	6	6	6	7	91	73	60	55	47
Shares Outstanding	- -	- -	- -	- -	1	1	1	1	1	2	21	17	8	7	11
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt	2	- -	-4	-3	-2	-3	-1	-1	-1	-2	-85	-68	-50	-15	-19
Net Debt to Equity	-122.17	-23.95	-40.44	-34.71	-29.45	-42.84	-18.37	-10.22	-16.11	-32.97	-94.97	-93.6	-126.99	-29.24	-53.18
Tangible Common Equity Ratio	-109.21	-52.19	93.52	73.55	82.34	88.66	77.5	66.73	58.82	81.2	99.19	99.16	44.72	93.89	72.11
Current Ratio	0.28	0.49	11.2	2.74	3.18	6.1	1.99	0.88	1.01	3.14	121.38	116.18	6.8	7.68	45.28
Cash Conversion Cycle	-34,577.73	-71,019.81	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

Cash Flow Statement API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

+ Net Income	-2	-2	-27	-10	-6	-4	-7	-4	-4	-4	-4	-4	- -	31	-19
+ Depreciation & Amortization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Non-Cash Items	1	1	26	4	3	1	2	1	1	- -	- -	1	-3	-35	16
+ Stock-Based Compensation	- -	- -	- -	6	2	1	2	1	1	- -	- -	1	1	- -	1
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	- -	2
+ Other Non-Cash Adj	1	1	26	-3	- -	- -	- -	- -	- -	- -	- -	- -	-5	-35	14
+ Chg in Non-Cash Work Cap	- -	- -	- -	2	-1	- -	- -	- -	- -	- -	- -	- -	- -	1	-2
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inc (Dec) in Accts Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	-2
+ Inc (Dec) in Other	- -	- -	- -	1	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	- -	- -	-2	-5	-4	-3	-5	-3	-2	-3	-4	-4	-2	-3	-5
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	-1	-4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	-1	-4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	1	9	4	4	5	3	2	3	5	87	-14	-28	-3	- -
+ Increase in Capital Stock	- -	1	9	4	4	5	3	2	3	5	87	- -	- -	- -	- -
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-14	-28	-3	- -
+ Net Change in LT Investment	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-7	-3
+ Dec in LT Investment	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-7	-3
+ Net Cash From Acq & Div	-1	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	-1	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-5	- -	5
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	-1	-1	-4	- -	- -	- -	- -	- -	- -	- -	- -	- -	-5	-7	2
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash From Debt	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	17	-22	7
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	1	1	9	4	4	5	3	2	3	5	87	-14	-11	-25	7
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	- -	- -	3	-1	-1	2	-2	-1	- -	1	83	-17	-18	-35	3
EBITDA	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5
EBITDA Margin (%)	-2,891.5	-13,851.65	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow	- -	-1	-5	-5	-4	-3	-5	-3	-2	-3	-4	-4	-2	-3	-5
Net Cash Paid for Acquisitions	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2	-3	- -
Free Cash Flow to Equity	1	- -	-2	-5	-4	-3	-5	-3	-2	-3	-4	-4	7	-16	-4
Free Cash Flow per Basic Share	-1.04	-3.53	-12.99	-9.71	-8.66	-5.92	-7.86	-3.92	-2.59	-2.3	-0.27	-0.19	-0.22	-0.41	-0.62
Price/Free Cash Flow	- -	168.08	91.41	-24.77	-12.26	-20.39	-10.65	-16.2	-14.68	-11.93	-8.78	-15	-9.44	-3.05	-1.17
Cash Flow to Net Income	0.14	0.24	0.06	0.46	0.72	0.75	0.74	0.71	0.61	0.94	0.97	0.88	-6.45	-0.1	0.27
Capital Expenditures	- -	-1	-4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -